Literature DB >> 10089937

Localization of type IV collagen alpha chain in the myocardium of dilated and hypertrophic cardiomyopathy.

T Watanabe1, S Kusachi, A Yamanishi, H Kumashiro, H Nunoyama, I Sano, M Nakahama, T Murakami, I Naito, Y Ninomiya, T Tsuji.   

Abstract

A total of 6 alpha chains [alpha 1 (IV) to alpha 6 (IV)] have been identified in type IV collagen. We examined the localization of these chains in the myocardium of patients with dilated (DCM) and hypertrophic (HCM) cardiomyopathy. The localization of alpha 1 (IV)-alpha 6 (IV) in biopsy specimens of 5 patients with DCM and 4 with HCM was examined using immunohistochemistry with monoclonal antibodies. Both alpha 1 (IV) and alpha 2 (IV) immunostaining formed thin homogeneous outlines around myocytes in control hearts. In the DCM specimens, alpha 1 (IV) and alpha 2 (IV) immunostaining formed thick and irregular patterns around myocytes. Staining for alpha 1(IV) and alpha 2 (IV) was also observed in some enlarged intercellular spaces. In 3 DCM hearts, moderate staining for alpha 1 (IV) and alpha 2 (IV) was observed in small replacement fibrotic lesions. In large replacement fibrotic lesions, no alpha 1 (IV) or alpha 2 (IV) staining was observed. In the HCM specimens, alpha 1 (IV) and alpha 2 (IV) staining formed thick homogeneous patterns around myocytes. In the enlarged intercellular spaces, no alpha 1 (IV) or alpha 2 (IV) staining was observed. No labeling for alpha 3 (IV)-alpha 6 (IV) was observed in any heart examined. In conclusion, the present results demonstrate that type IV collagen consisting of alpha 1 and alpha 2 chains appears in the fibrotic lesions of DCM, indicating its contribution to the development of fibrotic changes in the myocardium of DCM patients. In contrast, type IV collagen was restricted to the myocyte membrane in the HCM hearts. Fibrotic processes in the intercellular spaces may differ between DCM and HCM hearts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10089937     DOI: 10.1536/ihj.39.753

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  7 in total

Review 1.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

2.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

3.  New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process.

Authors:  Carolina Gil-Cayuela; Esther Roselló-LLetí; Ana Ortega; Estefanía Tarazón; Juan Carlos Triviño; Luis Martínez-Dolz; José Ramón González-Juanatey; Francisca Lago; Manuel Portolés; Miguel Rivera
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

4.  Canstatin inhibits hypoxia-induced apoptosis through activation of integrin/focal adhesion kinase/Akt signaling pathway in H9c2 cardiomyoblasts.

Authors:  Hiroki Kanazawa; Keisuke Imoto; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

5.  Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.

Authors:  Akira Sugiyama; Ayaka Mitsui; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2019-02-07       Impact factor: 1.267

6.  Collagen-Targeted Peptides for Molecular Imaging of Diffuse Cardiac Fibrosis.

Authors:  Martin Ezeani; Asif Noor; Karen Alt; Sean Lal; Paul S Donnelly; Christoph E Hagemeyer; Be'eri Niego
Journal:  J Am Heart Assoc       Date:  2021-09-13       Impact factor: 5.501

Review 7.  Dissecting the Role of the Extracellular Matrix in Heart Disease: Lessons from the Drosophila Genetic Model.

Authors:  Chris J R Hughes; J Roger Jacobs
Journal:  Vet Sci       Date:  2017-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.